Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS

Summary

The purpose of this study is to learn about the pharmacokinetics and pharmacodynamics of RPC1063 in RMS.

Timeline

Start

2016-06-23

Primary completion

2017-10-20

Completion

2017-10-20

Publications

• Harris S, Tran JQ, Southworth H, Spencer CM, Cree BAC, Zamvil SS. Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 31;7(5):e839. doi: 10.1212/NXI.0000000000000839. Print 2020 Sep.

Drugs

Indications